A 10 year asthma programme in Finland: major change for the better

Background: A National Asthma Programme was undertaken in Finland from 1994 to 2004 to improve asthma care and prevent an increase in costs. The main goal was to lessen the burden of asthma to individuals and society. Methods: The action programme focused on implementation of new knowledge, especially for primary care. The main premise underpinning the campaign was that asthma is an inflammatory disease and requires anti-inflammatory treatment from the outset. The key for implementation was an effective network of asthma-responsible professionals and development of a post hoc evaluation strategy. In 1997 Finnish pharmacies were included in the Pharmacy Programme and in 2002 a Childhood Asthma mini-Programme was launched. Results: The incidence of asthma is still increasing, but the burden of asthma has decreased considerably. The number of hospital days has fallen by 54% from 110 000 in 1993 to 51 000 in 2003, 69% in relation to the number of asthmatics (n = 135 363 and 207 757, respectively), with the trend still downwards. In 1993, 7212 patients of working age (9% of 80 133 asthmatics) received a disability pension from the Social Insurance Institution compared with 1741 in 2003 (1.5% of 116 067 asthmatics). The absolute decrease was 76%, and 83% in relation to the number of asthmatics. The increase in the cost of asthma (compensation for disability, drugs, hospital care, and outpatient doctor visits) ended: in 1993 the costs were €218 million which had fallen to €213.5 million in 2003. Costs per patient per year have decreased 36% (from €1611 to €1031). Conclusion: It is possible to reduce the morbidity of asthma and its impact on individuals as well as on society. Improvements would have taken place without the programme, but not of this magnitude.

[1]  Martyn R Partridge,et al.  British Guideline on the Management of Asthma , 2008, Thorax.

[2]  T. Holtz,et al.  Time to Sputum Culture Conversion in Multidrug-Resistant Tuberculosis: Predictors and Relationship to Treatment Outcome , 2006, Annals of Internal Medicine.

[3]  L. Hirsch Competing interests: none declared. , 2006 .

[4]  S. Weiland,et al.  No increase in the prevalence of asthma, allergies, and atopic sensitisation among children in Germany: 1992–2001 , 2005, Thorax.

[5]  T. Haahtela,et al.  Trends in prevalence of asthma and allergy in Finnish young men: nationwide study, 1966-2003 , 2005, BMJ : British Medical Journal.

[6]  Sean D Sullivan,et al.  Daily versus as-needed corticosteroids for mild persistent asthma. , 2005, The New England journal of medicine.

[7]  T. Haahtela,et al.  Signs of reversing trends in prevalence of asthma , 2005, Allergy.

[8]  M. Jaakkola,et al.  Smoking and asthma in adults , 2004, European Respiratory Journal.

[9]  S. Hartikainen,et al.  Achievements and shortcomings of Finnish asthma care , 2004, Scandinavian journal of public health.

[10]  Kevin B Weiss,et al.  Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. , 2004, The Journal of allergy and clinical immunology.

[11]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[12]  T. Klaukka,et al.  The asthma programme of Finland: an evaluation survey in primary health care. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  J. Wedzicha,et al.  New year: new editors , 2003 .

[14]  Smoking , nicotine dependency and interventions for cessation , 2003 .

[15]  A. Heloma Impact and Implementation of the Finnish Tobacco Act in Workplaces , 2003 .

[16]  E. Valovirta,et al.  Inpatient resource utilisation in younger (2–5 yrs) and older (6–14 yrs) asthmatic children in Finland , 2002, European Respiratory Journal.

[17]  M. Woodhead Community-acquired pneumonia guidelines: much guidance, but not much evidence , 2002, European Respiratory Journal.

[18]  Brigit VanGraafeiland,et al.  National Asthma Education and Prevention Program. , 2002, The Nurse practitioner.

[19]  John W. Wilson,et al.  Asthma Management Handbook , 2002 .

[20]  T. Haahtela,et al.  Asthma programme in Finland: a community problem needs community solutions , 2001, Thorax.

[21]  K. Kurppa,et al.  Work is related to a substantial portion of adult-onset asthma incidence in the Finnish population. , 2001, American journal of respiratory and critical care medicine.

[22]  G. Crompton,et al.  Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. , 2001, The European respiratory journal.

[23]  S. Sarna,et al.  Acute childhood asthma in Finland:A retrospective review of hospital admissions from 1976 to 1995 , 2000, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[24]  R. Dahl,et al.  Nordic consensus report on asthma management , 2000 .

[25]  K. Chung,et al.  Delivering effective asthma care--how do we implement asthma guidelines? , 2000, The European respiratory journal.

[26]  Pierre Ernst,et al.  Canadian asthma consensus report, 1999 , 1999 .

[27]  L. Boulet,et al.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[28]  R. de Marco,et al.  International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). , 1999, The European respiratory journal.

[29]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[30]  I. Kunnamo,et al.  [Evidence-based treatment guidelines]. , 1997, Duodecim; laaketieteellinen aikakauskirja.

[31]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[32]  Tari Haahtela,et al.  Randomised comparison of guided self management and traditional treatment of asthma over one year , 1996, BMJ.

[33]  T. Haahtela,et al.  Asthma Programme in Finland 1994–2004 Report of a Working Group , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[34]  T. Haahtela,et al.  Asthma programme in Finland 1994-2004. Report of a Working Group. , 1996 .

[35]  North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management in adults. , 1996, BMJ.

[36]  T. Haahtela,et al.  Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. , 1994, The New England journal of medicine.

[37]  J. Grimshaw,et al.  Achieving health gain through clinical guidelines II: Ensuring guidelines change medical practice. , 1994, Quality in health care : QHC.

[38]  T. Haahtela,et al.  Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. , 1991, The New England journal of medicine.

[39]  J. Crofton,et al.  Chronic airways disease. The smoking component. , 1989, Chest.

[40]  T. Haahtela,et al.  Damage of the airway epithelium and bronchial reactivity in patients with asthma. , 1985, The American review of respiratory disease.